Moogene Medi Co., Ltd. (XKON:322970)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,075.00
+50.00 (2.47%)
At close: Aug 1, 2025, 3:30 PM KST

Innovid Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2019FY 2018FY 2017
Period Ending
Dec '19 Dec '18 Dec '17
Net Income
-2,084-1,474-856.65
Depreciation & Amortization
219.49171.2449.61
Loss (Gain) From Sale of Assets
-19.48-
Loss (Gain) on Equity Investments
--1
Stock-Based Compensation
351.88--
Other Operating Activities
86.35159.26174.93
Change in Accounts Receivable
--0.22-
Change in Income Taxes
---0.72
Change in Other Net Operating Assets
26.81-115.85-18.62
Operating Cash Flow
-1,399-1,240-650.45
Capital Expenditures
-58.98-515.15-109.57
Sale (Purchase) of Intangibles
--4.39-53.56
Investment in Securities
---1
Other Investing Activities
68.36-137.79-67.67
Investing Cash Flow
-3.76-624.32-470.61
Short-Term Debt Issued
--310
Long-Term Debt Issued
-309.64-
Total Debt Issued
-309.64310
Short-Term Debt Repaid
--310-
Total Debt Repaid
--310-
Net Debt Issued (Repaid)
--0.36310
Issuance of Common Stock
-6,405550
Repurchase of Common Stock
-13.99--
Financing Cash Flow
-13.996,405860
Miscellaneous Cash Flow Adjustments
---0
Net Cash Flow
-1,4174,541-261.07
Free Cash Flow
-1,458-1,755-760.02
Free Cash Flow Margin
-11257.85%-1738.61%-105.35%
Free Cash Flow Per Share
-232.34-843.09-422.31
Levered Free Cash Flow
-759.73-1,272-
Unlevered Free Cash Flow
-742.97-1,258-
Change in Net Working Capital
-33.5414.04-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.